Paper41847697
Thromboembolic disease in testicular germ cell tumors-real-world evidence of three Portuguese institutions.
Albuquerque J and 11 others. Front Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Thromboembolic disease in testicular germ cell tumors-real-world evidence of three Portuguese institutions. Papers, record 41847697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41847697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thromboembolic disease in testicular germ cell tumors-real-world evidence of three Portuguese institutions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21810688 | High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21810688 | PubMed |
| 2 | 36795409 | Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36795409 | PubMed |
| 3 | 29507532 | Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look! | Thromb J | 2018 | https://conductscience.org/library/papers/29507532 | PubMed |
| 4 | 35277970 | Global patterns in testicular cancer incidence and mortality in 2020. | Int J Cancer | 2022 | https://conductscience.org/library/papers/35277970 | PubMed |
| 5 | 28980454 | Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study. | Cancer Med | 2017 | https://conductscience.org/library/papers/28980454 | PubMed |
| 6 | 17922809 | Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity. | J Thromb Haemost | 2007 | https://conductscience.org/library/papers/17922809 | PubMed |
| 7 | 39899286 | Testicular Germ Cell Tumors: A Review. | JAMA | 2025 | https://conductscience.org/library/papers/39899286 | PubMed |
| 8 | 22389165 | Cancer and coagulation. | Am J Hematol | 2012 | https://conductscience.org/library/papers/22389165 | PubMed |
| 9 | 34667955 | Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study. | Eur Urol Open Sci | 2021 | https://conductscience.org/library/papers/34667955 | PubMed |
| 10 | 35065204 | Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2022 | https://conductscience.org/library/papers/35065204 | PubMed |
| 11 | 18216292 | Development and validation of a predictive model for chemotherapy-associated thrombosis. | Blood | 2008 | https://conductscience.org/library/papers/18216292 | PubMed |
| 12 | 31821065 | Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/31821065 | PubMed |
| 13 | 31715650 | Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). | Cancer Med | 2020 | https://conductscience.org/library/papers/31715650 | PubMed |
| 14 | 26240226 | Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26240226 | PubMed |
| 15 | 33722419 | Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021. | Eur Urol | 2021 | https://conductscience.org/library/papers/33722419 | PubMed |
| 16 | 34121471 | Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study. | Clin Appl Thromb Hemost | 2021 | https://conductscience.org/library/papers/34121471 | PubMed |
| 17 | 40324110 | Key Updates in Testicular Cancer: Optimizing Survivorship and Survival. | Am Soc Clin Oncol Educ Book | 2025 | https://conductscience.org/library/papers/40324110 | PubMed |
| 18 | 28122896 | Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients. | J Natl Cancer Inst | 2017 | https://conductscience.org/library/papers/28122896 | PubMed |
| 19 | 20028501 | Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report. | BMC Cancer | 2009 | https://conductscience.org/library/papers/20028501 | PubMed |
| 20 | 38893201 | Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893201 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41847697
GET https://conductscience.org/api/papers/v1/41847697/references?page=2